BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3322924)

  • 61. Clinical review of lansoprazole.
    Lockhart SP
    Br J Clin Pract Suppl; 1994; 75():48-55; discussion 56-7. PubMed ID: 8060802
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Omeprazole. A new inhibitor of gastric secretion].
    Farup PG
    Tidsskr Nor Laegeforen; 1989 Aug; 109(22):2156-7. PubMed ID: 2772881
    [No Abstract]   [Full Text] [Related]  

  • 63. Clinical implications of the gastrointestinal hormones.
    Debas HT
    Can J Surg; 1979 Jan; 22(1):10-6. PubMed ID: 36214
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Safety aspects of omeprazole.
    Sölvell L
    Scand J Gastroenterol Suppl; 1986; 118():129-35. PubMed ID: 3460168
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Summary of the 34th meeting of the Food and Drug Administration Gastrointestinal Drugs Advisory Committee. March 15 and 16, 1989 (omeprazole and domperidone).
    Stern WR
    Am J Gastroenterol; 1989 Nov; 84(11):1351-5. PubMed ID: 2816869
    [No Abstract]   [Full Text] [Related]  

  • 66. [Successful treatment of severe reflux esophagitis with omeprazole: a therapeutic success?].
    Müller-Lissner S
    Z Gastroenterol; 1989 Feb; 27(2):131-2. PubMed ID: 2658391
    [No Abstract]   [Full Text] [Related]  

  • 67. [Comment on the contribution: "Effect of omeprazole on serum gastrin levels: influence of age and sex" by Koop et al].
    Miederer SE
    Z Gastroenterol; 1991 Apr; 29(4):177-8. PubMed ID: 1866976
    [No Abstract]   [Full Text] [Related]  

  • 68. Omeprazole.
    Gazzard BG
    Br J Clin Pract; 1989 Nov; 43(11):408-11. PubMed ID: 2611096
    [No Abstract]   [Full Text] [Related]  

  • 69. [A meeting of experts in Washington. Omeprazole: important progress in the treatment of gastric pathology. Activity and cicatrization rate in ulcer are highlighted].
    Rev Clin Esp; 1989; 185(3):suppl 2p.. PubMed ID: 2623222
    [No Abstract]   [Full Text] [Related]  

  • 70. The clinical safety of omeprazole.
    Sölvell L
    Digestion; 1990; 47 Suppl 1():59-63; discussion 76. PubMed ID: 2093017
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Cigarette smoking and pathophysiology of diseases of the digestive system--facts and hypotheses. I. Cigarette smoking and physiology of the digestive system].
    Nowak A; Jonderko K
    Pol Arch Med Wewn; 1990 Mar; 83(3):137-42. PubMed ID: 2216937
    [No Abstract]   [Full Text] [Related]  

  • 72. [New pharmacologic perspectives in the therapy with antisecretory agents: omeprazole].
    Esplugues JV; García AG
    Rev Clin Esp; 1991 Apr; 188(6):301-5. PubMed ID: 1780532
    [No Abstract]   [Full Text] [Related]  

  • 73. The safety of omeprazole: true or false?
    Sachs G
    Gastroenterology; 1994 May; 106(5):1400-1. PubMed ID: 8174907
    [No Abstract]   [Full Text] [Related]  

  • 74. Gastric carcinoid tumours in patients with Zollinger-Ellison syndrome on long-term omeprazole.
    Goldfain D; le Bodic MF; Lavergne A; Galian A; Modigliani R
    Lancet; 1989 Apr; 1(8641):776-7. PubMed ID: 2564577
    [No Abstract]   [Full Text] [Related]  

  • 75. [Omeprazole: a step forward in the therapy of acido-peptic disease].
    Piqué JM
    Med Clin (Barc); 1992 Jun; 99(5):179-82. PubMed ID: 1507897
    [No Abstract]   [Full Text] [Related]  

  • 76. Losec (omeprazole/MSD).
    Swartz ML
    Gastroenterol Nurs; 1990; 12(4):274-6. PubMed ID: 2288939
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Omeprazole decreased formation of monoethylglycinexylidide in a patient with chronic active hepatitis.
    Campo N; Alvarez S; Borzone S; Caglieris S; Zentilin P; Testa R
    Am J Gastroenterol; 1994 Aug; 89(8):1271-2. PubMed ID: 8053457
    [No Abstract]   [Full Text] [Related]  

  • 78. [Pro-kinetic agents. Developments and indications].
    Layer P
    Z Gastroenterol Verh; 1991 Mar; 26():157-8. PubMed ID: 1714133
    [No Abstract]   [Full Text] [Related]  

  • 79. [Bullous pemphigoid secondary corticoresistant. Inhibitory role of omeprazole on corticosteroid metabolism?].
    Chosidow O; Joly P; Laurent-Puig P; Prost C; Espagne E; Wechsler J; Roujeau JC; Revuz J
    Ann Dermatol Venereol; 1991; 118(1):45-6. PubMed ID: 2018306
    [No Abstract]   [Full Text] [Related]  

  • 80. Conventional dose of omeprazole alters gastric flora.
    Karmeli Y; Stalnikowitz R; Eliakim R; Rahav G
    Dig Dis Sci; 1995 Sep; 40(9):2070-3. PubMed ID: 7555466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.